E08.62

Diabetes mellitus due to underlying condition with skin complications

Header / non-billable

Choose the additional character

E08.62 needs more characters to be billable. Pick the specific code below.

This code does not map to a risk-adjusting HCC in the loaded models.

Coding notes

Excludes 1 never coded together · Excludes 2 may co-exist

Inherited from E08Diabetes mellitus due to underlying condition
Excludes 1

drug or chemical induced diabetes mellitus (E09.-) gestational diabetes (O24.4-) neonatal diabetes mellitus (P70.2) postpancreatectomy diabetes mellitus (E13.-) postprocedural diabetes mellitus (E13.-) secondary diabetes mellitus NEC (E13.-) type 1 diabetes mellitus (E10.-) type 2 diabetes mellitus (E11.-)

Use additional

code to identify control using: injectable non-insulin antidiabetic drugs (Z79.85) insulin (Z79.4) oral antidiabetic drugs (Z79.84) oral hypoglycemic drugs (Z79.84)

Code first

the underlying condition, such as: congenital rubella (P35.0) Cushing's syndrome (E24.-) cystic fibrosis (E84.-) malignant neoplasm (C00-C96) malnutrition (E40-E46) pancreatitis and other diseases of the pancreas (K85-K86.-)

Inherited from chapter 4Endocrine, nutritional and metabolic diseases
Excludes 1

transitory endocrine and metabolic disorders specific to newborn (P70-P74)

Note

All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.

Official Guidelines for E08.62

FY 2026 ›
I.C.4Chapter-specific guidanceChapter 4: Endocrine, Nutritional, and Metabolic Diseases (E00-E89)

Subsections

Sections that reference E08.62

Sections whose FY 2026 text names E08.62, its E08 category, or a range containing it — the chapter guidance above is the authoritative source.